Marleen Meyers

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.

James L. Speyer, M D Green, Anne Zeleniuch‐Jacquotte et al. · Journal of Clinical Oncology · 1992 · 323 citations

Medicine, Oncology, Pharmacology +17

Nutrition Literacy among Cancer Survivors: Feasibility Results from the Healthy Eating and Living Against Breast Cancer (HEAL-BCa) Study: a Pilot Randomized Controlled Trial

Jieying Jiang, Marissa L. Buchan, Marleen Meyers et al. · Journal of Cancer Education · 2017 · 48 citations

Public Health, Nutrition, Nutritional Sciences +17

A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer

James L. Speyer, M.D. Green, Joseph J. Sanger et al. · Cancer Treatment Reviews · 1990 · 25 citations

Medicine, Oncology, Pharmacology +13

Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer

Maryann Kwa, Xiaochun Li, Yelena Novik et al. · Breast Cancer Research and Treatment · 2017 · 22 citations

Medicine, Immunology, Oncology +17

Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis

Matteo Malgaroli, Kristin L. Szuhany, Gabriella Riley et al. · Journal of Cancer Survivorship · 2022 · 21 citations · Full text

Medicine, Oncology, Psychology +14